Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Aug-12 4:26 PM View:  | Glaxosmithkline Plc Director 10% Owner | Human Genome Sciences Inc. (HGSI) | 02-Aug-12 | Market Purchase | 62,646,200 | $14.25 | $892,707,968.00 | 37% 171.07M to 233.72M | (< 1%) |
| 01-Aug-12 5:28 PM View: | Glaxosmithkline Plc Director 10% Owner | Human Genome Sciences Inc. (HGSI) | 01-Aug-12 | Market Purchase | 1,788,190 | $14.25 | $25,481,600.00 | 1% 163.6M to 165.38M | (< 1%) |
| 03-Aug-12 4:26 PM View: | Glaxosmithkline Plc Director 10% Owner | Human Genome Sciences Inc. (HGSI) | 01-Aug-12 | Market Purchase | 5,686,720 | $14.25 | $81,035,696.00 | 3% 165.38M to 171.07M | (< 1%) |
| 01-Aug-12 1:57 PM View: | Lawlor Augustine Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 4,166 | $14.25 | $59,365.50 | (9%) 46.59K to 42.43K | < 1% |
| 01-Aug-12 1:57 PM View: | Goddard Colin Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 4,166 | $14.25 | $59,365.50 | (39%) 10.73K to 6.56K | < 1% |
| 01-Aug-12 1:57 PM View: | Karabelas Argeris N Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 4,166 | $14.25 | $59,365.50 | (19%) 21.94K to 17.78K | < 1% |
| 01-Aug-12 1:57 PM View: | Goddard Colin Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 6,560 | $14.25 | $93,480.00 | (100%) 6.56K to 0 | < 1% |
| 01-Aug-12 11:53 AM View: | Davis James H Exec. VP, Gen Counsel & Sec. | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 165,032 | $14.25 | $2,351,710.00 | (100%) 165.03K to 0 | < 1% |
| 01-Aug-12 1:57 PM View: | Norden Gregory Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 4,166 | $14.25 | $59,365.50 | (56%) 7.5K to 3.33K | < 1% |
| 01-Aug-12 1:57 PM View: | Baxter Allan Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 2,500 | $14.25 | $35,625.00 | (100%) 2.5K to 0 | < 1% |
| 01-Aug-12 1:57 PM View: | Gowen Maxine Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 11,320 | $14.25 | $161,312.00 | (100%) 11.32K to 0 | < 1% |
| 01-Aug-12 1:57 PM View: | Lamattina John L Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 4,166 | $14.25 | $59,365.50 | (9%) 47.01K to 42.84K | < 1% |
| 01-Aug-12 1:57 PM View: | Ha Ngoc Tuan Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 16,807 | $14.25 | $239,500.00 | (100%) 16.81K to 0 | < 1% |
| 01-Aug-12 11:53 AM View: | Simpson Curran Sr. VP, Operations | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 42,216 | $14.25 | $601,578.00 | (100%) 42.22K to 0 | < 1% |
| 01-Aug-12 1:57 PM View: | Lawlor Augustine Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 42,429 | $14.25 | $604,613.00 | (100%) 42.43K to 0 | < 1% |
| 01-Aug-12 1:57 PM View: | Young Robert C Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 23,018 | $14.25 | $328,006.00 | (62%) 36.85K to 13.83K | < 1% |
| 01-Aug-12 1:57 PM View: | Young Robert C Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 13,834 | $14.25 | $197,134.00 | (100%) 13.83K to 0 | < 1% |
| 01-Aug-12 1:57 PM View: | Morrow George J Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 10,834 | $14.25 | $154,384.00 | (100%) 10.83K to 0 | < 1% |
| 01-Aug-12 1:57 PM View: | Gowen Maxine Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 17,343 | $14.25 | $247,138.00 | (61%) 28.66K to 11.32K | < 1% |
| 01-Aug-12 11:53 AM View: | Southwell David P Chief Financial Officer | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 90,835 | $14.25 | $1,294,400.00 | (100%) 90.83K to 0 | < 1% |
| 01-Aug-12 11:53 AM View: | Stump David C Exec. Vice President | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 68,701 | $14.25 | $978,989.00 | (78%) 88.28K to 19.58K | < 1% |
| 01-Aug-12 1:57 PM View: | Lamattina John L Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 42,843 | $14.25 | $610,513.00 | (100%) 42.84K to 0 | < 1% |
| 01-Aug-12 1:57 PM View: | Karabelas Argeris N Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 17,776 | $14.25 | $253,308.00 | (100%) 17.78K to 0 | < 1% |
| 01-Aug-12 1:57 PM View: | Norden Gregory Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 3,334 | $14.25 | $47,509.50 | (100%) 3.33K to 0 | < 1% |
| 01-Aug-12 11:53 AM View: | McKay Susan D Bateson Senior Vice President | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 62,270 | $14.25 | $887,348.00 | (100%) 62.27K to 0 | < 1% |
| 01-Aug-12 1:57 PM View: | Morrow George J Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 4,166 | $14.25 | $59,365.50 | (28%) 15.0K to 10.83K | < 1% |
| 01-Aug-12 5:28 PM View: | Glaxosmithkline Plc Director 10% Owner | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Market Purchase | 4,934,740 | $14.25 | $70,320,096.00 | 3% 158.66M to 163.6M | (< 1%) |
| 01-Aug-12 11:53 AM View: | Stump David C Exec. Vice President | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 19,576 | $14.25 | $278,958.00 | (100%) 19.58K to 0 | < 1% |
| 01-Aug-12 1:57 PM View: | Ha Ngoc Tuan Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 4,166 | $14.25 | $59,365.50 | (20%) 20.97K to 16.81K | < 1% |
| 01-Aug-12 1:57 PM View: | Danzig Richard J Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 4,166 | $14.25 | $59,365.50 | (36%) 11.5K to 7.33K | < 1% |
| 01-Aug-12 1:57 PM View: | Danzig Richard J Director | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 7,334 | $14.25 | $104,510.00 | (100%) 7.33K to 0 | < 1% |
| 01-Aug-12 11:53 AM View: | Labinger Barry Exec VP & CCO | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 49,842 | $14.25 | $710,248.00 | (100%) 49.84K to 0 | < 1% |
| 26-Jul-12 11:09 AM View: | Labinger Barry Exec VP & CCO | Human Genome Sciences Inc. (HGSI) | 25-Jul-12 | Option Exercise | 31,480 | $1.86 | $58,609.60 | 171% 18.36K to 49.84K | |
| 01-Aug-12 3:22 PM View: | Watkins Thomas Chief Executive Officer Director | Human Genome Sciences Inc. (HGSI) | 25-Jul-12 | Gift | 166,075 | $14.25 | $2,366,570.00 | (100%) 166.07K to 0 | < 1% |
| 26-Jul-12 9:00 AM View: | Stump David C Exec. Vice President | Human Genome Sciences Inc. (HGSI) | 24-Jul-12 | Option Exercise | 68,701 | $6.20 | $426,266.00 | 351% 19.58K to 88.28K | |
| 24-Jul-12 1:22 PM View: | Davis James H Exec. VP, Gen Counsel & Sec. | Human Genome Sciences Inc. (HGSI) | 23-Jul-12 | Option Exercise | 76,293 | $7.32 | $558,598.00 | 86% 88.74K to 165.03K | |
| 11-Jul-12 10:45 AM View: | Ha Ngoc Tuan Director | Human Genome Sciences Inc. (HGSI) | 10-Jul-12 | Grant | 462 | $13.64 | $6,301.68 | 2% 20.51K to 20.97K | 0% |
| 11-Jul-12 10:45 AM View: | Lawlor Augustine Director | Human Genome Sciences Inc. (HGSI) | 10-Jul-12 | Grant | 1,704 | $13.64 | $23,242.60 | 4% 44.89K to 46.59K | 0% |
| 11-Jul-12 10:45 AM View: | Karabelas Argeris N Director | Human Genome Sciences Inc. (HGSI) | 10-Jul-12 | Grant | 728 | $13.64 | $9,929.92 | 3% 21.21K to 21.94K | 0% |
| 21-May-12 9:41 AM View: | Young Robert C Director | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 7% 34.35K to 36.85K | |
| 21-May-12 9:41 AM View: | Gowen Maxine Director | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 10% 26.16K to 28.66K | |
| 21-May-12 9:41 AM View: | Ha Ngoc Tuan Director | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 14% 18.01K to 20.51K | |
| 21-May-12 9:41 AM View: | Lawlor Augustine Director | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 6% 42.39K to 44.89K | |
| 21-May-12 9:41 AM View: | Karabelas Argeris N Director | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 13% 18.71K to 21.21K | |
| 21-May-12 9:41 AM View: | Morrow George J Director | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 20% 12.5K to 15.0K | |
| 21-May-12 9:41 AM View: | Danzig Richard J Director | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 28% 9.0K to 11.5K | |
| 21-May-12 9:41 AM View: | Goddard Colin Director | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 30% 8.23K to 10.73K | |
| 21-May-12 9:41 AM View: | Norden Gregory Director | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 50% 5.0K to 7.5K | |
| 21-May-12 9:41 AM View: | Baxter Allan Director | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 100% 0 to 2.5K | |
| 21-May-12 9:41 AM View: | Lamattina John L Director | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 6% 44.51K to 47.01K |
